These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 24835558
1. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study. Biedenbach DJ, Bouchillon SK, Johnson SA, Hoban DJ, Hackel M. Clin Ther; 2014 Jun 01; 36(6):953-60. PubMed ID: 24835558 [Abstract] [Full Text] [Related]
2. In Vitro Activity of Retapamulin and Antimicrobial Susceptibility Patterns in a Longitudinal Collection of Methicillin-Resistant Staphylococcus aureus Isolates from a Veterans Affairs Medical Center. Harrington AT, Black JA, Clarridge JE. Antimicrob Agents Chemother; 2015 Dec 14; 60(3):1298-303. PubMed ID: 26666950 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study. Kircik LH. J Drugs Dermatol; 2012 Jul 14; 11(7):858-60. PubMed ID: 22777229 [Abstract] [Full Text] [Related]
13. Retapamulin Activity Against Pediatric Strains of Mupirocin-resistant Methicillin-resistant Staphylococcus aureus. Patel AB, Lighter J, Fulmer Y, Copin R, Ratner AJ, Shopsin B. Pediatr Infect Dis J; 2021 Jul 01; 40(7):637-638. PubMed ID: 33657598 [Abstract] [Full Text] [Related]
17. Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa. Shittu AO, Udo EE, Lin J. BMC Infect Dis; 2009 Jan 28; 9():10. PubMed ID: 19175912 [Abstract] [Full Text] [Related]
18. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic. Rittenhouse S, Singley C, Hoover J, Page R, Payne D. Antimicrob Agents Chemother; 2006 Nov 28; 50(11):3886-8. PubMed ID: 17065626 [Abstract] [Full Text] [Related]